ST. PAUL, MN--(Marketwire - April 01, 2008) - GelStat Corporation (PINKSHEETS: GSAC), a consumer healthcare company primarily focused on the development and marketing of over-the-counter (OTC) products for the safe and effective treatment of pain and inflammation, announces today that Mr. Michael Chavanu has been appointed as the Company’s new Chairman of the Board replacing Mr. James LaFlamme who resigned to pursue other opportunities which prohibit him from serving on any public company boards. Mr. Chavanu has served on the Company’s board since June of 2006.
